The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Pharmacovigilance And Drug Safety Software Market Through 2030?
The pharmacovigilance and drug safety software market has seen rapid expansion in recent years. It is anticipated to increase from $2.53 billion in 2025 to $2.86 billion in 2026, at a compound annual growth rate (CAGR) of 12.8%. This historical growth can be attributed to factors such as a rise in adverse drug reaction reporting, the globalization of clinical trials, stringent drug safety regulations, an increase in pharmaceutical production, and evolving requirements for post-marketing surveillance.
The market for pharmacovigilance and drug safety software is projected for swift expansion over the coming years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. This projected growth during the forecast period stems from factors such as the expansion of AI-driven signal detection, the growth in biologics and specialty drugs, heightened regulatory scrutiny, the increasing outsourcing of pharmacovigilance services, and the demand for real-time safety analytics. Key trends anticipated for the forecast period encompass the growing adoption of cloud-based pharmacovigilance platforms, an increasing focus on real-world evidence monitoring, a rising automation in adverse event reporting, the expansion of integrated drug safety systems, and a higher demand for regulatory compliance solutions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
What Are The Main Drivers Accelerating The Growth Of The Pharmacovigilance And Drug Safety Software Market?
The increasing need for personalized medicine is anticipated to drive expansion in the pharmacovigilance and drug safety software market. This approach, also known as precision medicine, involves customizing treatment strategies based on an individual’s unique genetic, biological, and lifestyle attributes. Its increasing popularity stems from better treatment results, more effective prevention and early diagnosis methods, and improved cost-efficiency. The pharmacovigilance and drug safety software market facilitates personalized medicine through the integration of pharmacogenetics, real-time data analysis, and post-marketing surveillance, aiming to enhance patient safety, oversee customized treatments, and reinforce risk management. For example, data from February 2024, provided by the Personalized Medicine Coalition (PMC), a US-based non-profit organization, revealed that the FDA approved 16 new personalized therapies for rare diseases in 2023, a significant increase from 6 approvals in 2022. Consequently, the expanding demand for personalized medicine is acting as a key driver for the growth of the pharmacovigilance and drug safety software market.
How Is The Pharmacovigilance And Drug Safety Software Market Examined Through Segment Analysis?
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
Which Trends Are Expected To Shape The Pharmacovigilance And Drug Safety Software Market?
Major companies operating in the pharmacovigilance and drug safety software market are prioritizing the development of innovative technologies, such as cloud-based data lake platforms, to enhance adverse event monitoring, improve regulatory compliance, and elevate overall patient safety across clinical trials and post-market surveillance. A cloud-based data lake platform is defined as a scalable, centralized system capable of storing and analyzing vast quantities of structured and unstructured safety data in real time, thereby enabling advanced analytics, AI/ML modeling, and more efficient case processing within pharmacovigilance workflows. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced CorEvidence, its proprietary cloud-based data lake platform crafted to optimize pharmacovigilance processes by boosting safety data management and case processing efficiency, specifically supporting post-authorization safety studies within clinical research registries.
Which Industry Players Are Present In The Pharmacovigilance And Drug Safety Software Market?
Major companies operating in the pharmacovigilance and drug safety software market are IQVIA, Oracle Corporation, ArisGlobal, RXLogix, Anju Software Inc., EXTEDO GmbH, Sarjen Systems Pvt Ltd, Ennov Group, AB Cube, Clinevo Technologies, Accenture plc, International Business Machines Corporation, Capgemini SE, Cognizant Technology Solutions, Wipro Limited, Genpact, Indegene Limited, PharmaLex, Deloitte Touche Tohmatsu Limited, Parexel
Access The Complete Pharmacovigilance And Drug Safety Software Market Report:
Which Region Stands As The Largest Contributor To The Pharmacovigilance And Drug Safety Software Market?
North America was the largest region in the pharmacovigilance and drug safety software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmacovigilance And Drug Safety Software Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
Browse Through More Reports Similar to the Global Pharmacovigilance And Drug Safety Software Market 2026, By The Business Research Company
Pharmacovigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Patient Safety And Risk Management Software Market Report 2026
Therapeutic Drug Monitoring Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model